CT26.CL25 Syngeneic Model

Rincon Bio offers efficacy studies using the CT26.CL25 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:

Syngeneic

Organ:

Colon

ATCC link (if available):

https://www.atcc.org/products/crl-2639

Cellosaurus Link:

Derivation:

Fibroblastic subclones from NNMU-induced colon carcinoma in BALB/c mice, modified to express a tumor-specific antigen that makes it more sensitive to immunotherapy

Mutations:

KRAS

NCI60:

No

Weeks from stratification to termination (average):

2.5

CT26.CL25 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the CT26.CL25 syngeneic model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

Request Quote

All Xenograft Models

All Syngeneic Models

The Cancer Model CRO

rincon bio